LISA ENGELHARDT: Open Payments
NPI 1790098473 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 14 payments from 7 companies in 2025. Trend: 2023 $860 · 2024 $653 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $300 |
| Lilly USA, LLC | 3 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Novo Nordisk Inc | 1 | $31 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: OTEZLA, MOUNJARO, JARDIANCE, Wegovy, TZIELD, SHINGRIX, WAINUA.
Industry payments across CA — which companies pay providers there.
